If you're looking for stocks that can make dramatic movements in a short time frame, the biotechnology space has what you ...

Carlsmed, a Carlsbad-based medical technology firm, began trading publicly on the Nasdaq Stock Market under the ticker symbol ...

HOUSTON, TX / ACCESS Newswire / July 18, 2025 /CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a ...

The Company’s common stock is expected to begin trading on a split-adjusted basis when the markets open on July 22, 2025 under the Company’s existing trading symbol “GBIO” with the new CUSIP number ...

West Pharmaceutical Services ( ($WST) ) has provided an update. On July 21, 2025, West Pharmaceutical Services announced the appointment of Robert ...

CMND-100, Clearmind’s lead compound, leverages the innovative molecule 5-methoxy-2-aminoindane (MEAI) to offer a potential breakthrough in AUD treatment. Preclinical studies have shown promising ...

Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases ...

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

HOUSTON, TX / ACCESS Newswire / July 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pr ...

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharma company focused on treating brain and CNS cancers, will implement a 1-for-12 reverse stock split eff ...

FOXO Technologies Inc. (NYSE American: FOXO) ('FOXO” or the 'Company”), today announced that its Board of Directors has approved a 1 for 1.99 reverse stock split of the Company’s Class A common stock, ...

BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”) today announced the appointment of Kristin Yarema, Ph ...